down arrow

Ipca Labs

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,330.25
36.7 (2.84%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 88.08 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,310.001,340.00

52 Week

1,060.951,757.65
Valuation
Technical
Day's Volume

CASH

88.08 k (-71.84%) Volume

Shareholding (Sep 2024)

FII

10.83%

Held by 195 FIIs

DII

34.23%

Held by 55 DIIs

Promoter

46.30%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Bearish range

  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 2.19% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
2

With ROE of 9.2, it has a Very Expensive valuation with a 4.9 Price to Book Value

3

Reducing Promoter Confidence

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 33,749 Cr (Large Cap)

stock-summary
P/E

45.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.31%

stock-summary
Debt Equity

0.04

stock-summary
Return on Equity

9.16%

stock-summary
Price to Book

4.90

Revenue and Profits (1 Year):
Net Sales:
2,245 Cr
(Quarterly Results - Dec 2024)
Net Profit:
248 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.31%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-19.66%
0.13%
-19.53%
1 Year
0.03%
0.30%
0.33%
2 Years
60.41%
0.85%
61.26%
3 Years
28.33%
1.04%
29.37%
4 Years
27.6%
1.65%
29.25%
5 Years
66.09%
3.26%
69.35%

Latest dividend: 2 per share ex-dividend date: Nov-27-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
14.39%
EBIT Growth (5y)
11.45%
EBIT to Interest (avg)
68.03
Debt to EBITDA (avg)
0.78
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.99
Tax Ratio
32.89%
Dividend Payout Ratio
18.54%
Pledged Shares
0
Institutional Holding
46.75%
ROCE (avg)
19.75%
ROE (avg)
13.93%
Valuation key factors
Factor
Value
P/E Ratio
45
Industry P/E
33
Price to Book Value
4.90
EV to EBIT
27.07
EV to EBITDA
20.45
EV to Capital Employed
4.73
EV to Sales
3.80
PEG Ratio
1.20
Dividend Yield
0.31%
ROCE (Latest)
15.57%
ROE (Latest)
9.16%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 33 Schemes (28.55%)

FIIs

Held by 195 FIIs (10.83%)

Promoter with highest holding

Kaygee Investments Private Limited (21.47%)

Highest Public shareholder

Hdfc Mutual Fund - Hdfc Mid-cap Opportunities Fund (8.46%)

Individual Investors Holdings

6.93%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -4.65% vs 12.53% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 8.13% vs 19.37% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,245.37",
          "val2": "2,354.90",
          "chgp": "-4.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "463.08",
          "val2": "441.48",
          "chgp": "4.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.81",
          "val2": "22.56",
          "chgp": "-25.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "248.14",
          "val2": "229.48",
          "chgp": "8.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.62%",
          "val2": "18.75%",
          "chgp": "1.87%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 22.89% vs 13.57% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 36.98% vs 7.29% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,447.53",
          "val2": "3,619.17",
          "chgp": "22.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "834.20",
          "val2": "668.38",
          "chgp": "24.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "46.61",
          "val2": "75.50",
          "chgp": "-38.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-39.49",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "421.72",
          "val2": "307.88",
          "chgp": "36.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.76%",
          "val2": "18.47%",
          "chgp": "0.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 18.00% vs 19.85% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 37.33% vs 23.55% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,692.90",
          "val2": "5,672.02",
          "chgp": "18.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,297.28",
          "val2": "999.26",
          "chgp": "29.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "63.42",
          "val2": "108.90",
          "chgp": "-41.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "28.97",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "669.86",
          "val2": "487.76",
          "chgp": "37.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.38%",
          "val2": "17.62%",
          "chgp": "1.76%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 23.39% vs 7.11% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 16.13% vs -46.69% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,705.04",
          "val2": "6,244.32",
          "chgp": "23.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,321.16",
          "val2": "926.77",
          "chgp": "42.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "138.27",
          "val2": "45.54",
          "chgp": "203.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-107.75",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "547.35",
          "val2": "471.32",
          "chgp": "16.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.15%",
          "val2": "14.84%",
          "chgp": "2.31%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
2,245.37
2,354.90
-4.65%
Operating Profit (PBDIT) excl Other Income
463.08
441.48
4.89%
Interest
16.81
22.56
-25.49%
Exceptional Items
0.00
0.00
Consolidate Net Profit
248.14
229.48
8.13%
Operating Profit Margin (Excl OI)
20.62%
18.75%
1.87%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -4.65% vs 12.53% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 8.13% vs 19.37% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
4,447.53
3,619.17
22.89%
Operating Profit (PBDIT) excl Other Income
834.20
668.38
24.81%
Interest
46.61
75.50
-38.26%
Exceptional Items
0.00
-39.49
100.00%
Consolidate Net Profit
421.72
307.88
36.98%
Operating Profit Margin (Excl OI)
18.76%
18.47%
0.29%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 22.89% vs 13.57% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 36.98% vs 7.29% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
6,692.90
5,672.02
18.00%
Operating Profit (PBDIT) excl Other Income
1,297.28
999.26
29.82%
Interest
63.42
108.90
-41.76%
Exceptional Items
0.00
28.97
-100.00%
Consolidate Net Profit
669.86
487.76
37.33%
Operating Profit Margin (Excl OI)
19.38%
17.62%
1.76%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 18.00% vs 19.85% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 37.33% vs 23.55% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
7,705.04
6,244.32
23.39%
Operating Profit (PBDIT) excl Other Income
1,321.16
926.77
42.56%
Interest
138.27
45.54
203.62%
Exceptional Items
-107.75
0.00
Consolidate Net Profit
547.35
471.32
16.13%
Operating Profit Margin (Excl OI)
17.15%
14.84%
2.31%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 23.39% vs 7.11% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 16.13% vs -46.69% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Ipca Laboratories Ltd stock-summary
stock-summary
Ipca Laboratories Ltd
Large Cap
Pharmaceuticals & Drugs
Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments. The products of the Company are now sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market.
Company Coordinates stock-summary
Company Details
48 Kandivli Industrial Estate, Kandivli (West) Mumbai Maharashtra : 400067
stock-summary
Tel: 91-22-66474444
stock-summary
http://www.ipca.com
stock-summary
ipca@ipca.co.in/investors@ipca.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."